Specifically, women with GR levels ≥ 55.8 U/L exhibited a 2.226-fold increased likelihood of developing postmenopausal osteoporosis, underscoring a robust association between elevated GR levels and disease occurrence. This evidence concerns the gene GSR and postmenopausal osteoporosis.